Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6XQB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,909
Award facts
- Contract value 100% obligated
- $32,908.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,908.96 on August 4, 2025, for the supply of Xiaflex 0.9 mg vials. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The award carries no set-aside designation, and performance is scheduled for completion by August 25, 2025, at the company's location in Park Ridge, Illinois. The contract is funded by the Medical Supply Chain, a defense-sector agency supporting pharmaceutical supply needs for military healthcare facilities.
Xiaflex is a specialty pharmaceutical product used in clinical settings, and this delivery order represents a routine replenishment under DMS Pharmaceutical Group's established framework agreement with the DLA. The company has demonstrated consistent capability in supplying branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems. As a primary distributor within the federal pharmaceutical supply chain, DMS Pharmaceutical Group fulfills critical supply requirements for Department of Defense medical facilities nationwide through its SPE2DB contract vehicle, which enables streamlined procurement of an extensive portfolio of pharmaceutical products across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DX25F6XQB?
SPE2DX25F6XQB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2DX25F6XQB worth?
The government has obligated $32,909 on SPE2DX25F6XQB.
Is contract SPE2DX25F6XQB an order under another contract?
Yes. SPE2DX25F6XQB is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XQB competed?
The extent of competition for SPE2DX25F6XQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award